| Gene symbol | CD38 | Synonyms | ADPRC 1, ADPRC1, cADPR1 | Type of gene | protein-coding |
| Chromosome | 4 | Map location | 4p15.32 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | CD38 molecule | ||||
| GTO ID | GTC0869 |
| Trial ID | ChiCTR2000033970 |
| Disease | Hematologic Cancer |
| Altered gene | CD38 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD38 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | Single-center, open, single-arm clinical study of the safety and efficacy of whole-human anti-CD38 CAR-T infusion in the treatment of CD38 positive refractory recurrent malignant hematologic tumors |
| Year | 2020 |
| Country | China |
| Company sponsor | The Affiliated Hospital of Xuzhou Medical University |
| Cohort 1 | |||||||
|
|||||||